nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Etoposide—urinary bladder cancer	0.284	1	CrCtD
Teniposide—Podofilox—Etoposide—urinary bladder cancer	0.161	1	CrCrCtD
Teniposide—Topoisomerase Inhibitors—Etoposide—urinary bladder cancer	0.144	0.43	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Epirubicin—urinary bladder cancer	0.0989	0.296	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Doxorubicin—urinary bladder cancer	0.0915	0.274	CiPCiCtD
Teniposide—TOP2A—Valrubicin—urinary bladder cancer	0.067	0.433	CbGbCtD
Teniposide—ABCC6—Cisplatin—urinary bladder cancer	0.0151	0.0977	CbGbCtD
Teniposide—ABCC6—Etoposide—urinary bladder cancer	0.0149	0.096	CbGbCtD
Teniposide—TOP2A—Epirubicin—urinary bladder cancer	0.0101	0.0655	CbGbCtD
Teniposide—ABCC6—Doxorubicin—urinary bladder cancer	0.0101	0.0654	CbGbCtD
Teniposide—TOP2A—Etoposide—urinary bladder cancer	0.00791	0.0511	CbGbCtD
Teniposide—TOP2A—Doxorubicin—urinary bladder cancer	0.00539	0.0348	CbGbCtD
Teniposide—ABCG2—Fluorouracil—urinary bladder cancer	0.00351	0.0227	CbGbCtD
Teniposide—ABCG2—Carboplatin—urinary bladder cancer	0.00349	0.0226	CbGbCtD
Teniposide—ABCG2—Cisplatin—urinary bladder cancer	0.00298	0.0193	CbGbCtD
Teniposide—ABCG2—Etoposide—urinary bladder cancer	0.00293	0.0189	CbGbCtD
Teniposide—CYP3A4—Thiotepa—urinary bladder cancer	0.00234	0.0151	CbGbCtD
Teniposide—ABCG2—Doxorubicin—urinary bladder cancer	0.002	0.0129	CbGbCtD
Teniposide—ABCG2—Methotrexate—urinary bladder cancer	0.00194	0.0125	CbGbCtD
Teniposide—CYP3A5—Etoposide—urinary bladder cancer	0.00162	0.0105	CbGbCtD
Teniposide—CYP2C9—Fluorouracil—urinary bladder cancer	0.00131	0.00843	CbGbCtD
Teniposide—CYP2C9—Cisplatin—urinary bladder cancer	0.00111	0.00716	CbGbCtD
Teniposide—NCOA1—prostate gland—urinary bladder cancer	0.000987	0.094	CbGeAlD
Teniposide—NCOA1—seminal vesicle—urinary bladder cancer	0.000835	0.0795	CbGeAlD
Teniposide—NCOA3—prostate gland—urinary bladder cancer	0.000688	0.0655	CbGeAlD
Teniposide—NCOA1—urethra—urinary bladder cancer	0.000661	0.063	CbGeAlD
Teniposide—CYP2C19—urine—urinary bladder cancer	0.00066	0.0629	CbGeAlD
Teniposide—CYP3A4—Etoposide—urinary bladder cancer	0.000633	0.00409	CbGbCtD
Teniposide—CYP2C9—urine—urinary bladder cancer	0.000512	0.0488	CbGeAlD
Teniposide—NCOA1—vagina—urinary bladder cancer	0.000488	0.0464	CbGeAlD
Teniposide—NCOA3—smooth muscle tissue—urinary bladder cancer	0.000487	0.0464	CbGeAlD
Teniposide—Etoposide—GSTT1—urinary bladder cancer	0.000471	0.49	CrCbGaD
Teniposide—NCOA3—renal system—urinary bladder cancer	0.000469	0.0447	CbGeAlD
Teniposide—NCOA3—urethra—urinary bladder cancer	0.000461	0.0439	CbGeAlD
Teniposide—CYP3A4—Doxorubicin—urinary bladder cancer	0.000432	0.00279	CbGbCtD
Teniposide—ABCC6—renal system—urinary bladder cancer	0.000412	0.0393	CbGeAlD
Teniposide—TOP2A—prostate gland—urinary bladder cancer	0.000404	0.0384	CbGeAlD
Teniposide—CYP3A4—urine—urinary bladder cancer	0.00039	0.0372	CbGeAlD
Teniposide—NCOA3—female reproductive system—urinary bladder cancer	0.000376	0.0358	CbGeAlD
Teniposide—Etoposide—GSTP1—urinary bladder cancer	0.000372	0.387	CrCbGaD
Teniposide—NCOA3—vagina—urinary bladder cancer	0.00034	0.0323	CbGeAlD
Teniposide—NCOA1—lymph node—urinary bladder cancer	0.000315	0.03	CbGeAlD
Teniposide—NCOA3—Idarubicin—Valrubicin—urinary bladder cancer	0.000304	0.314	CbGdCrCtD
Teniposide—NCOA3—lymph node—urinary bladder cancer	0.00022	0.0209	CbGeAlD
Teniposide—ABCG2—prostate gland—urinary bladder cancer	0.000201	0.0192	CbGeAlD
Teniposide—TOP2A—vagina—urinary bladder cancer	0.000199	0.019	CbGeAlD
Teniposide—CYP3A5—prostate gland—urinary bladder cancer	0.000187	0.0178	CbGeAlD
Teniposide—ABCG2—seminal vesicle—urinary bladder cancer	0.00017	0.0162	CbGeAlD
Teniposide—ABCC6—Podofilox—Etoposide—urinary bladder cancer	0.000154	0.159	CbGdCrCtD
Teniposide—ABCG2—urethra—urinary bladder cancer	0.000135	0.0128	CbGeAlD
Teniposide—TOP2A—lymph node—urinary bladder cancer	0.000129	0.0123	CbGeAlD
Teniposide—CYP3A5—renal system—urinary bladder cancer	0.000127	0.0121	CbGeAlD
Teniposide—Etoposide—PTGS2—urinary bladder cancer	0.000118	0.123	CrCbGaD
Teniposide—CYP2C19—vagina—urinary bladder cancer	0.000117	0.0111	CbGeAlD
Teniposide—NCOA3—Idarubicin—Epirubicin—urinary bladder cancer	0.000106	0.109	CbGdCrCtD
Teniposide—CYP2C9—female reproductive system—urinary bladder cancer	0.0001	0.00956	CbGeAlD
Teniposide—ABCG2—vagina—urinary bladder cancer	9.93e-05	0.00946	CbGeAlD
Teniposide—NCOA3—Idarubicin—Doxorubicin—urinary bladder cancer	9.79e-05	0.101	CbGdCrCtD
Teniposide—CYP3A4—renal system—urinary bladder cancer	9.55e-05	0.0091	CbGeAlD
Teniposide—CYP3A5—vagina—urinary bladder cancer	9.22e-05	0.00878	CbGeAlD
Teniposide—CYP3A4—female reproductive system—urinary bladder cancer	7.65e-05	0.00729	CbGeAlD
Teniposide—ABCG2—lymph node—urinary bladder cancer	6.42e-05	0.00612	CbGeAlD
Teniposide—Neuropathy—Epirubicin—urinary bladder cancer	5.05e-05	0.00167	CcSEcCtD
Teniposide—Hypertension—Thiotepa—urinary bladder cancer	5.05e-05	0.00166	CcSEcCtD
Teniposide—Arrhythmia—Gemcitabine—urinary bladder cancer	5.05e-05	0.00166	CcSEcCtD
Teniposide—Sepsis—Methotrexate—urinary bladder cancer	4.99e-05	0.00165	CcSEcCtD
Teniposide—Alopecia—Gemcitabine—urinary bladder cancer	4.99e-05	0.00165	CcSEcCtD
Teniposide—Arrhythmia—Fluorouracil—urinary bladder cancer	4.96e-05	0.00164	CcSEcCtD
Teniposide—Alopecia—Fluorouracil—urinary bladder cancer	4.91e-05	0.00162	CcSEcCtD
Teniposide—Flushing—Cisplatin—urinary bladder cancer	4.89e-05	0.00161	CcSEcCtD
Teniposide—Neoplasm—Epirubicin—urinary bladder cancer	4.87e-05	0.0016	CcSEcCtD
Teniposide—Confusional state—Thiotepa—urinary bladder cancer	4.81e-05	0.00159	CcSEcCtD
Teniposide—Infection—Thiotepa—urinary bladder cancer	4.74e-05	0.00156	CcSEcCtD
Teniposide—Arrhythmia—Cisplatin—urinary bladder cancer	4.7e-05	0.00155	CcSEcCtD
Teniposide—Neuropathy—Doxorubicin—urinary bladder cancer	4.68e-05	0.00154	CcSEcCtD
Teniposide—Sepsis—Epirubicin—urinary bladder cancer	4.67e-05	0.00154	CcSEcCtD
Teniposide—Thrombocytopenia—Thiotepa—urinary bladder cancer	4.67e-05	0.00154	CcSEcCtD
Teniposide—Tachycardia—Thiotepa—urinary bladder cancer	4.66e-05	0.00153	CcSEcCtD
Teniposide—Alopecia—Cisplatin—urinary bladder cancer	4.65e-05	0.00153	CcSEcCtD
Teniposide—Anorexia—Thiotepa—urinary bladder cancer	4.55e-05	0.0015	CcSEcCtD
Teniposide—Anaemia—Gemcitabine—urinary bladder cancer	4.54e-05	0.0015	CcSEcCtD
Teniposide—Phlebitis—Epirubicin—urinary bladder cancer	4.54e-05	0.0015	CcSEcCtD
Teniposide—Neoplasm—Doxorubicin—urinary bladder cancer	4.5e-05	0.00148	CcSEcCtD
Teniposide—Flushing—Etoposide—urinary bladder cancer	4.48e-05	0.00148	CcSEcCtD
Teniposide—Hepatic function abnormal—Epirubicin—urinary bladder cancer	4.47e-05	0.00147	CcSEcCtD
Teniposide—Anaemia—Fluorouracil—urinary bladder cancer	4.47e-05	0.00147	CcSEcCtD
Teniposide—Leukopenia—Gemcitabine—urinary bladder cancer	4.4e-05	0.00145	CcSEcCtD
Teniposide—Chills—Etoposide—urinary bladder cancer	4.33e-05	0.00143	CcSEcCtD
Teniposide—Leukopenia—Fluorouracil—urinary bladder cancer	4.33e-05	0.00143	CcSEcCtD
Teniposide—Sepsis—Doxorubicin—urinary bladder cancer	4.32e-05	0.00142	CcSEcCtD
Teniposide—Alopecia—Etoposide—urinary bladder cancer	4.26e-05	0.0014	CcSEcCtD
Teniposide—Hypertension—Gemcitabine—urinary bladder cancer	4.25e-05	0.0014	CcSEcCtD
Teniposide—Anaemia—Cisplatin—urinary bladder cancer	4.24e-05	0.0014	CcSEcCtD
Teniposide—Phlebitis—Doxorubicin—urinary bladder cancer	4.2e-05	0.00138	CcSEcCtD
Teniposide—Chest pain—Gemcitabine—urinary bladder cancer	4.19e-05	0.00138	CcSEcCtD
Teniposide—TOP2A—Daunorubicin—Valrubicin—urinary bladder cancer	4.18e-05	0.0432	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Valrubicin—urinary bladder cancer	4.18e-05	0.0432	CbGdCrCtD
Teniposide—TOP2A—Epirubicin—Valrubicin—urinary bladder cancer	4.18e-05	0.0432	CbGdCrCtD
Teniposide—TOP2A—Doxorubicin—Valrubicin—urinary bladder cancer	4.18e-05	0.0432	CbGdCrCtD
Teniposide—Decreased appetite—Thiotepa—urinary bladder cancer	4.15e-05	0.00137	CcSEcCtD
Teniposide—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	4.14e-05	0.00136	CcSEcCtD
Teniposide—Chest pain—Fluorouracil—urinary bladder cancer	4.12e-05	0.00136	CcSEcCtD
Teniposide—Leukopenia—Cisplatin—urinary bladder cancer	4.1e-05	0.00135	CcSEcCtD
Teniposide—Oedema—Gemcitabine—urinary bladder cancer	4.01e-05	0.00132	CcSEcCtD
Teniposide—Infection—Gemcitabine—urinary bladder cancer	3.99e-05	0.00131	CcSEcCtD
Teniposide—Confusional state—Fluorouracil—urinary bladder cancer	3.98e-05	0.00131	CcSEcCtD
Teniposide—Oedema—Fluorouracil—urinary bladder cancer	3.95e-05	0.0013	CcSEcCtD
Teniposide—Feeling abnormal—Thiotepa—urinary bladder cancer	3.93e-05	0.0013	CcSEcCtD
Teniposide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	3.93e-05	0.0013	CcSEcCtD
Teniposide—Infection—Fluorouracil—urinary bladder cancer	3.92e-05	0.00129	CcSEcCtD
Teniposide—Gastrointestinal pain—Thiotepa—urinary bladder cancer	3.9e-05	0.00129	CcSEcCtD
Teniposide—Anaemia—Etoposide—urinary bladder cancer	3.88e-05	0.00128	CcSEcCtD
Teniposide—Hyperhidrosis—Gemcitabine—urinary bladder cancer	3.88e-05	0.00128	CcSEcCtD
Teniposide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	3.86e-05	0.00127	CcSEcCtD
Teniposide—Liver function test abnormal—Methotrexate—urinary bladder cancer	3.86e-05	0.00127	CcSEcCtD
Teniposide—Tachycardia—Fluorouracil—urinary bladder cancer	3.85e-05	0.00127	CcSEcCtD
Teniposide—Anorexia—Gemcitabine—urinary bladder cancer	3.83e-05	0.00126	CcSEcCtD
Teniposide—Urticaria—Thiotepa—urinary bladder cancer	3.79e-05	0.00125	CcSEcCtD
Teniposide—Body temperature increased—Thiotepa—urinary bladder cancer	3.77e-05	0.00124	CcSEcCtD
Teniposide—Abdominal pain—Thiotepa—urinary bladder cancer	3.77e-05	0.00124	CcSEcCtD
Teniposide—Anorexia—Fluorouracil—urinary bladder cancer	3.76e-05	0.00124	CcSEcCtD
Teniposide—Leukopenia—Etoposide—urinary bladder cancer	3.76e-05	0.00124	CcSEcCtD
Teniposide—Hypotension—Gemcitabine—urinary bladder cancer	3.75e-05	0.00124	CcSEcCtD
Teniposide—Oedema—Cisplatin—urinary bladder cancer	3.74e-05	0.00123	CcSEcCtD
Teniposide—Infection—Cisplatin—urinary bladder cancer	3.72e-05	0.00122	CcSEcCtD
Teniposide—Hypotension—Fluorouracil—urinary bladder cancer	3.69e-05	0.00122	CcSEcCtD
Teniposide—Thrombocytopenia—Cisplatin—urinary bladder cancer	3.66e-05	0.00121	CcSEcCtD
Teniposide—Tachycardia—Cisplatin—urinary bladder cancer	3.65e-05	0.0012	CcSEcCtD
Teniposide—Hypertension—Etoposide—urinary bladder cancer	3.63e-05	0.00119	CcSEcCtD
Teniposide—Hyperhidrosis—Cisplatin—urinary bladder cancer	3.62e-05	0.00119	CcSEcCtD
Teniposide—Liver function test abnormal—Epirubicin—urinary bladder cancer	3.61e-05	0.00119	CcSEcCtD
Teniposide—Dyspnoea—Gemcitabine—urinary bladder cancer	3.58e-05	0.00118	CcSEcCtD
Teniposide—Chest pain—Etoposide—urinary bladder cancer	3.57e-05	0.00118	CcSEcCtD
Teniposide—Anorexia—Cisplatin—urinary bladder cancer	3.57e-05	0.00118	CcSEcCtD
Teniposide—Dyspnoea—Fluorouracil—urinary bladder cancer	3.52e-05	0.00116	CcSEcCtD
Teniposide—Hypersensitivity—Thiotepa—urinary bladder cancer	3.51e-05	0.00116	CcSEcCtD
Teniposide—Hypotension—Cisplatin—urinary bladder cancer	3.5e-05	0.00115	CcSEcCtD
Teniposide—Decreased appetite—Gemcitabine—urinary bladder cancer	3.49e-05	0.00115	CcSEcCtD
Teniposide—Confusional state—Etoposide—urinary bladder cancer	3.46e-05	0.00114	CcSEcCtD
Teniposide—Decreased appetite—Fluorouracil—urinary bladder cancer	3.43e-05	0.00113	CcSEcCtD
Teniposide—Pancytopenia—Methotrexate—urinary bladder cancer	3.43e-05	0.00113	CcSEcCtD
Teniposide—Asthenia—Thiotepa—urinary bladder cancer	3.42e-05	0.00113	CcSEcCtD
Teniposide—Infection—Etoposide—urinary bladder cancer	3.4e-05	0.00112	CcSEcCtD
Teniposide—Neutropenia—Methotrexate—urinary bladder cancer	3.38e-05	0.00111	CcSEcCtD
Teniposide—Pruritus—Thiotepa—urinary bladder cancer	3.38e-05	0.00111	CcSEcCtD
Teniposide—Thrombocytopenia—Etoposide—urinary bladder cancer	3.36e-05	0.00111	CcSEcCtD
Teniposide—Tachycardia—Etoposide—urinary bladder cancer	3.34e-05	0.0011	CcSEcCtD
Teniposide—Liver function test abnormal—Doxorubicin—urinary bladder cancer	3.34e-05	0.0011	CcSEcCtD
Teniposide—Dyspnoea—Cisplatin—urinary bladder cancer	3.33e-05	0.0011	CcSEcCtD
Teniposide—Hyperhidrosis—Etoposide—urinary bladder cancer	3.31e-05	0.00109	CcSEcCtD
Teniposide—Feeling abnormal—Gemcitabine—urinary bladder cancer	3.31e-05	0.00109	CcSEcCtD
Teniposide—Anorexia—Etoposide—urinary bladder cancer	3.27e-05	0.00108	CcSEcCtD
Teniposide—Diarrhoea—Thiotepa—urinary bladder cancer	3.26e-05	0.00108	CcSEcCtD
Teniposide—Decreased appetite—Cisplatin—urinary bladder cancer	3.25e-05	0.00107	CcSEcCtD
Teniposide—Feeling abnormal—Fluorouracil—urinary bladder cancer	3.25e-05	0.00107	CcSEcCtD
Teniposide—Pancytopenia—Epirubicin—urinary bladder cancer	3.21e-05	0.00106	CcSEcCtD
Teniposide—Hypotension—Etoposide—urinary bladder cancer	3.2e-05	0.00106	CcSEcCtD
Teniposide—Body temperature increased—Gemcitabine—urinary bladder cancer	3.17e-05	0.00105	CcSEcCtD
Teniposide—Neutropenia—Epirubicin—urinary bladder cancer	3.16e-05	0.00104	CcSEcCtD
Teniposide—Stomatitis—Methotrexate—urinary bladder cancer	3.14e-05	0.00103	CcSEcCtD
Teniposide—Urticaria—Fluorouracil—urinary bladder cancer	3.13e-05	0.00103	CcSEcCtD
Teniposide—Body temperature increased—Fluorouracil—urinary bladder cancer	3.12e-05	0.00103	CcSEcCtD
Teniposide—Sweating—Methotrexate—urinary bladder cancer	3.09e-05	0.00102	CcSEcCtD
Teniposide—Feeling abnormal—Cisplatin—urinary bladder cancer	3.08e-05	0.00102	CcSEcCtD
Teniposide—Dyspnoea—Etoposide—urinary bladder cancer	3.06e-05	0.00101	CcSEcCtD
Teniposide—Vomiting—Thiotepa—urinary bladder cancer	3.03e-05	0.001	CcSEcCtD
Teniposide—Rash—Thiotepa—urinary bladder cancer	3.01e-05	0.000991	CcSEcCtD
Teniposide—Dermatitis—Thiotepa—urinary bladder cancer	3.01e-05	0.000991	CcSEcCtD
Teniposide—Headache—Thiotepa—urinary bladder cancer	2.99e-05	0.000985	CcSEcCtD
Teniposide—Decreased appetite—Etoposide—urinary bladder cancer	2.98e-05	0.000982	CcSEcCtD
Teniposide—Pancytopenia—Doxorubicin—urinary bladder cancer	2.97e-05	0.000978	CcSEcCtD
Teniposide—Body temperature increased—Cisplatin—urinary bladder cancer	2.96e-05	0.000975	CcSEcCtD
Teniposide—Neuropathy peripheral—Epirubicin—urinary bladder cancer	2.95e-05	0.000973	CcSEcCtD
Teniposide—Stomatitis—Epirubicin—urinary bladder cancer	2.94e-05	0.000968	CcSEcCtD
Teniposide—Neutropenia—Doxorubicin—urinary bladder cancer	2.92e-05	0.000963	CcSEcCtD
Teniposide—Hypersensitivity—Fluorouracil—urinary bladder cancer	2.91e-05	0.000958	CcSEcCtD
Teniposide—Haemoglobin—Methotrexate—urinary bladder cancer	2.9e-05	0.000957	CcSEcCtD
Teniposide—Haemorrhage—Methotrexate—urinary bladder cancer	2.89e-05	0.000952	CcSEcCtD
Teniposide—Sweating—Epirubicin—urinary bladder cancer	2.89e-05	0.000952	CcSEcCtD
Teniposide—Asthenia—Gemcitabine—urinary bladder cancer	2.88e-05	0.000949	CcSEcCtD
Teniposide—Pruritus—Gemcitabine—urinary bladder cancer	2.84e-05	0.000936	CcSEcCtD
Teniposide—Nausea—Thiotepa—urinary bladder cancer	2.83e-05	0.000934	CcSEcCtD
Teniposide—Feeling abnormal—Etoposide—urinary bladder cancer	2.82e-05	0.000931	CcSEcCtD
Teniposide—Gastrointestinal pain—Etoposide—urinary bladder cancer	2.8e-05	0.000924	CcSEcCtD
Teniposide—Pruritus—Fluorouracil—urinary bladder cancer	2.79e-05	0.00092	CcSEcCtD
Teniposide—TOP2A—Podofilox—Etoposide—urinary bladder cancer	2.79e-05	0.0288	CbGdCrCtD
Teniposide—Hypersensitivity—Cisplatin—urinary bladder cancer	2.76e-05	0.000908	CcSEcCtD
Teniposide—Diarrhoea—Gemcitabine—urinary bladder cancer	2.75e-05	0.000905	CcSEcCtD
Teniposide—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	2.73e-05	0.0009	CcSEcCtD
Teniposide—Urticaria—Etoposide—urinary bladder cancer	2.72e-05	0.000897	CcSEcCtD
Teniposide—Haemoglobin—Epirubicin—urinary bladder cancer	2.72e-05	0.000896	CcSEcCtD
Teniposide—Stomatitis—Doxorubicin—urinary bladder cancer	2.72e-05	0.000895	CcSEcCtD
Teniposide—Body temperature increased—Etoposide—urinary bladder cancer	2.71e-05	0.000893	CcSEcCtD
Teniposide—Abdominal pain—Etoposide—urinary bladder cancer	2.71e-05	0.000893	CcSEcCtD
Teniposide—Haemorrhage—Epirubicin—urinary bladder cancer	2.7e-05	0.000891	CcSEcCtD
Teniposide—Diarrhoea—Fluorouracil—urinary bladder cancer	2.7e-05	0.00089	CcSEcCtD
Teniposide—Asthenia—Cisplatin—urinary bladder cancer	2.68e-05	0.000885	CcSEcCtD
Teniposide—Sweating—Doxorubicin—urinary bladder cancer	2.67e-05	0.000881	CcSEcCtD
Teniposide—Chills—Methotrexate—urinary bladder cancer	2.59e-05	0.000854	CcSEcCtD
Teniposide—Diarrhoea—Cisplatin—urinary bladder cancer	2.56e-05	0.000844	CcSEcCtD
Teniposide—Alopecia—Methotrexate—urinary bladder cancer	2.55e-05	0.000842	CcSEcCtD
Teniposide—Vomiting—Gemcitabine—urinary bladder cancer	2.55e-05	0.000841	CcSEcCtD
Teniposide—Rash—Gemcitabine—urinary bladder cancer	2.53e-05	0.000834	CcSEcCtD
Teniposide—Dermatitis—Gemcitabine—urinary bladder cancer	2.53e-05	0.000833	CcSEcCtD
Teniposide—Hypersensitivity—Etoposide—urinary bladder cancer	2.52e-05	0.000832	CcSEcCtD
Teniposide—Haemoglobin—Doxorubicin—urinary bladder cancer	2.51e-05	0.000829	CcSEcCtD
Teniposide—Headache—Gemcitabine—urinary bladder cancer	2.51e-05	0.000829	CcSEcCtD
Teniposide—Flushing—Epirubicin—urinary bladder cancer	2.51e-05	0.000827	CcSEcCtD
Teniposide—Vomiting—Fluorouracil—urinary bladder cancer	2.51e-05	0.000827	CcSEcCtD
Teniposide—Haemorrhage—Doxorubicin—urinary bladder cancer	2.5e-05	0.000825	CcSEcCtD
Teniposide—Rash—Fluorouracil—urinary bladder cancer	2.49e-05	0.00082	CcSEcCtD
Teniposide—Dermatitis—Fluorouracil—urinary bladder cancer	2.49e-05	0.000819	CcSEcCtD
Teniposide—Headache—Fluorouracil—urinary bladder cancer	2.47e-05	0.000815	CcSEcCtD
Teniposide—Asthenia—Etoposide—urinary bladder cancer	2.46e-05	0.00081	CcSEcCtD
Teniposide—Chills—Epirubicin—urinary bladder cancer	2.43e-05	0.0008	CcSEcCtD
Teniposide—Pruritus—Etoposide—urinary bladder cancer	2.42e-05	0.000799	CcSEcCtD
Teniposide—Arrhythmia—Epirubicin—urinary bladder cancer	2.42e-05	0.000796	CcSEcCtD
Teniposide—Alopecia—Epirubicin—urinary bladder cancer	2.39e-05	0.000788	CcSEcCtD
Teniposide—Nausea—Gemcitabine—urinary bladder cancer	2.38e-05	0.000786	CcSEcCtD
Teniposide—Vomiting—Cisplatin—urinary bladder cancer	2.38e-05	0.000784	CcSEcCtD
Teniposide—Rash—Cisplatin—urinary bladder cancer	2.36e-05	0.000777	CcSEcCtD
Teniposide—Dermatitis—Cisplatin—urinary bladder cancer	2.36e-05	0.000777	CcSEcCtD
Teniposide—Diarrhoea—Etoposide—urinary bladder cancer	2.34e-05	0.000773	CcSEcCtD
Teniposide—Nausea—Fluorouracil—urinary bladder cancer	2.34e-05	0.000773	CcSEcCtD
Teniposide—Anaemia—Methotrexate—urinary bladder cancer	2.32e-05	0.000766	CcSEcCtD
Teniposide—Flushing—Doxorubicin—urinary bladder cancer	2.32e-05	0.000765	CcSEcCtD
Teniposide—Leukopenia—Methotrexate—urinary bladder cancer	2.25e-05	0.000742	CcSEcCtD
Teniposide—Chills—Doxorubicin—urinary bladder cancer	2.24e-05	0.00074	CcSEcCtD
Teniposide—Arrhythmia—Doxorubicin—urinary bladder cancer	2.23e-05	0.000737	CcSEcCtD
Teniposide—Nausea—Cisplatin—urinary bladder cancer	2.22e-05	0.000732	CcSEcCtD
Teniposide—Alopecia—Doxorubicin—urinary bladder cancer	2.21e-05	0.000729	CcSEcCtD
Teniposide—Vomiting—Etoposide—urinary bladder cancer	2.18e-05	0.000718	CcSEcCtD
Teniposide—Anaemia—Epirubicin—urinary bladder cancer	2.18e-05	0.000717	CcSEcCtD
Teniposide—Agitation—Epirubicin—urinary bladder cancer	2.16e-05	0.000713	CcSEcCtD
Teniposide—Rash—Etoposide—urinary bladder cancer	2.16e-05	0.000712	CcSEcCtD
Teniposide—Dermatitis—Etoposide—urinary bladder cancer	2.16e-05	0.000712	CcSEcCtD
Teniposide—Headache—Etoposide—urinary bladder cancer	2.15e-05	0.000708	CcSEcCtD
Teniposide—Chest pain—Methotrexate—urinary bladder cancer	2.14e-05	0.000706	CcSEcCtD
Teniposide—Leukopenia—Epirubicin—urinary bladder cancer	2.11e-05	0.000694	CcSEcCtD
Teniposide—Confusional state—Methotrexate—urinary bladder cancer	2.07e-05	0.000682	CcSEcCtD
Teniposide—Infection—Methotrexate—urinary bladder cancer	2.04e-05	0.000672	CcSEcCtD
Teniposide—Nausea—Etoposide—urinary bladder cancer	2.04e-05	0.000671	CcSEcCtD
Teniposide—Hypertension—Epirubicin—urinary bladder cancer	2.03e-05	0.00067	CcSEcCtD
Teniposide—Anaemia—Doxorubicin—urinary bladder cancer	2.01e-05	0.000663	CcSEcCtD
Teniposide—Thrombocytopenia—Methotrexate—urinary bladder cancer	2.01e-05	0.000662	CcSEcCtD
Teniposide—Chest pain—Epirubicin—urinary bladder cancer	2e-05	0.00066	CcSEcCtD
Teniposide—Agitation—Doxorubicin—urinary bladder cancer	2e-05	0.00066	CcSEcCtD
Teniposide—Hyperhidrosis—Methotrexate—urinary bladder cancer	1.98e-05	0.000654	CcSEcCtD
Teniposide—Anorexia—Methotrexate—urinary bladder cancer	1.96e-05	0.000645	CcSEcCtD
Teniposide—Leukopenia—Doxorubicin—urinary bladder cancer	1.95e-05	0.000643	CcSEcCtD
Teniposide—Confusional state—Epirubicin—urinary bladder cancer	1.94e-05	0.000638	CcSEcCtD
Teniposide—Oedema—Epirubicin—urinary bladder cancer	1.92e-05	0.000633	CcSEcCtD
Teniposide—Hypotension—Methotrexate—urinary bladder cancer	1.92e-05	0.000632	CcSEcCtD
Teniposide—Infection—Epirubicin—urinary bladder cancer	1.91e-05	0.000629	CcSEcCtD
Teniposide—Thrombocytopenia—Epirubicin—urinary bladder cancer	1.88e-05	0.00062	CcSEcCtD
Teniposide—Hypertension—Doxorubicin—urinary bladder cancer	1.88e-05	0.00062	CcSEcCtD
Teniposide—Tachycardia—Epirubicin—urinary bladder cancer	1.87e-05	0.000618	CcSEcCtD
Teniposide—Hyperhidrosis—Epirubicin—urinary bladder cancer	1.86e-05	0.000612	CcSEcCtD
Teniposide—Chest pain—Doxorubicin—urinary bladder cancer	1.85e-05	0.000611	CcSEcCtD
Teniposide—Anorexia—Epirubicin—urinary bladder cancer	1.83e-05	0.000604	CcSEcCtD
Teniposide—Dyspnoea—Methotrexate—urinary bladder cancer	1.83e-05	0.000603	CcSEcCtD
Teniposide—Hypotension—Epirubicin—urinary bladder cancer	1.79e-05	0.000592	CcSEcCtD
Teniposide—Confusional state—Doxorubicin—urinary bladder cancer	1.79e-05	0.000591	CcSEcCtD
Teniposide—Decreased appetite—Methotrexate—urinary bladder cancer	1.78e-05	0.000588	CcSEcCtD
Teniposide—Oedema—Doxorubicin—urinary bladder cancer	1.78e-05	0.000586	CcSEcCtD
Teniposide—Infection—Doxorubicin—urinary bladder cancer	1.77e-05	0.000582	CcSEcCtD
Teniposide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	1.74e-05	0.000574	CcSEcCtD
Teniposide—Tachycardia—Doxorubicin—urinary bladder cancer	1.73e-05	0.000572	CcSEcCtD
Teniposide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	1.72e-05	0.000566	CcSEcCtD
Teniposide—Dyspnoea—Epirubicin—urinary bladder cancer	1.71e-05	0.000564	CcSEcCtD
Teniposide—Anorexia—Doxorubicin—urinary bladder cancer	1.69e-05	0.000558	CcSEcCtD
Teniposide—Feeling abnormal—Methotrexate—urinary bladder cancer	1.69e-05	0.000558	CcSEcCtD
Teniposide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	1.68e-05	0.000553	CcSEcCtD
Teniposide—Decreased appetite—Epirubicin—urinary bladder cancer	1.67e-05	0.00055	CcSEcCtD
Teniposide—Hypotension—Doxorubicin—urinary bladder cancer	1.66e-05	0.000547	CcSEcCtD
Teniposide—Urticaria—Methotrexate—urinary bladder cancer	1.63e-05	0.000537	CcSEcCtD
Teniposide—Body temperature increased—Methotrexate—urinary bladder cancer	1.62e-05	0.000535	CcSEcCtD
Teniposide—Abdominal pain—Methotrexate—urinary bladder cancer	1.62e-05	0.000535	CcSEcCtD
Teniposide—Dyspnoea—Doxorubicin—urinary bladder cancer	1.58e-05	0.000522	CcSEcCtD
Teniposide—Feeling abnormal—Epirubicin—urinary bladder cancer	1.58e-05	0.000522	CcSEcCtD
Teniposide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	1.57e-05	0.000518	CcSEcCtD
Teniposide—TOP2A—Cytarabine—Gemcitabine—urinary bladder cancer	1.57e-05	0.0162	CbGdCrCtD
Teniposide—Decreased appetite—Doxorubicin—urinary bladder cancer	1.55e-05	0.000509	CcSEcCtD
Teniposide—Urticaria—Epirubicin—urinary bladder cancer	1.53e-05	0.000503	CcSEcCtD
Teniposide—Abdominal pain—Epirubicin—urinary bladder cancer	1.52e-05	0.000501	CcSEcCtD
Teniposide—Body temperature increased—Epirubicin—urinary bladder cancer	1.52e-05	0.000501	CcSEcCtD
Teniposide—Hypersensitivity—Methotrexate—urinary bladder cancer	1.51e-05	0.000498	CcSEcCtD
Teniposide—Asthenia—Methotrexate—urinary bladder cancer	1.47e-05	0.000485	CcSEcCtD
Teniposide—Feeling abnormal—Doxorubicin—urinary bladder cancer	1.46e-05	0.000483	CcSEcCtD
Teniposide—TOP2A—Daunorubicin—Epirubicin—urinary bladder cancer	1.45e-05	0.015	CbGdCrCtD
Teniposide—TOP2A—Doxorubicin—Epirubicin—urinary bladder cancer	1.45e-05	0.015	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Epirubicin—urinary bladder cancer	1.45e-05	0.015	CbGdCrCtD
Teniposide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	1.45e-05	0.000479	CcSEcCtD
Teniposide—Pruritus—Methotrexate—urinary bladder cancer	1.45e-05	0.000479	CcSEcCtD
Teniposide—Hypersensitivity—Epirubicin—urinary bladder cancer	1.42e-05	0.000466	CcSEcCtD
Teniposide—Urticaria—Doxorubicin—urinary bladder cancer	1.41e-05	0.000465	CcSEcCtD
Teniposide—Abdominal pain—Doxorubicin—urinary bladder cancer	1.41e-05	0.000463	CcSEcCtD
Teniposide—Body temperature increased—Doxorubicin—urinary bladder cancer	1.41e-05	0.000463	CcSEcCtD
Teniposide—Diarrhoea—Methotrexate—urinary bladder cancer	1.4e-05	0.000463	CcSEcCtD
Teniposide—Asthenia—Epirubicin—urinary bladder cancer	1.38e-05	0.000454	CcSEcCtD
Teniposide—Pruritus—Epirubicin—urinary bladder cancer	1.36e-05	0.000448	CcSEcCtD
Teniposide—TOP2A—Epirubicin—Doxorubicin—urinary bladder cancer	1.35e-05	0.0139	CbGdCrCtD
Teniposide—TOP2A—Daunorubicin—Doxorubicin—urinary bladder cancer	1.35e-05	0.0139	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Doxorubicin—urinary bladder cancer	1.35e-05	0.0139	CbGdCrCtD
Teniposide—Diarrhoea—Epirubicin—urinary bladder cancer	1.31e-05	0.000433	CcSEcCtD
Teniposide—Hypersensitivity—Doxorubicin—urinary bladder cancer	1.31e-05	0.000432	CcSEcCtD
Teniposide—Vomiting—Methotrexate—urinary bladder cancer	1.31e-05	0.00043	CcSEcCtD
Teniposide—Rash—Methotrexate—urinary bladder cancer	1.29e-05	0.000427	CcSEcCtD
Teniposide—Dermatitis—Methotrexate—urinary bladder cancer	1.29e-05	0.000426	CcSEcCtD
Teniposide—Headache—Methotrexate—urinary bladder cancer	1.29e-05	0.000424	CcSEcCtD
Teniposide—Asthenia—Doxorubicin—urinary bladder cancer	1.28e-05	0.00042	CcSEcCtD
Teniposide—Pruritus—Doxorubicin—urinary bladder cancer	1.26e-05	0.000414	CcSEcCtD
Teniposide—Vomiting—Epirubicin—urinary bladder cancer	1.22e-05	0.000403	CcSEcCtD
Teniposide—Nausea—Methotrexate—urinary bladder cancer	1.22e-05	0.000402	CcSEcCtD
Teniposide—Diarrhoea—Doxorubicin—urinary bladder cancer	1.22e-05	0.000401	CcSEcCtD
Teniposide—Rash—Epirubicin—urinary bladder cancer	1.21e-05	0.000399	CcSEcCtD
Teniposide—Dermatitis—Epirubicin—urinary bladder cancer	1.21e-05	0.000399	CcSEcCtD
Teniposide—Headache—Epirubicin—urinary bladder cancer	1.2e-05	0.000397	CcSEcCtD
Teniposide—Nausea—Epirubicin—urinary bladder cancer	1.14e-05	0.000376	CcSEcCtD
Teniposide—Vomiting—Doxorubicin—urinary bladder cancer	1.13e-05	0.000372	CcSEcCtD
Teniposide—TOP2A—Azacitidine—Gemcitabine—urinary bladder cancer	1.12e-05	0.0116	CbGdCrCtD
Teniposide—Rash—Doxorubicin—urinary bladder cancer	1.12e-05	0.000369	CcSEcCtD
Teniposide—Dermatitis—Doxorubicin—urinary bladder cancer	1.12e-05	0.000369	CcSEcCtD
Teniposide—Headache—Doxorubicin—urinary bladder cancer	1.11e-05	0.000367	CcSEcCtD
Teniposide—Nausea—Doxorubicin—urinary bladder cancer	1.06e-05	0.000348	CcSEcCtD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	1.05e-05	0.000448	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.03e-05	0.000443	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.03e-05	0.000442	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	1.03e-05	0.00044	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—SRC—urinary bladder cancer	1.02e-05	0.000437	CbGpPWpGaD
Teniposide—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	9.96e-06	0.000426	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—PTEN—urinary bladder cancer	9.9e-06	0.000424	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	9.84e-06	0.000421	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.83e-06	0.000421	CbGpPWpGaD
Teniposide—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.82e-06	0.00042	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—GSTP1—urinary bladder cancer	9.69e-06	0.000415	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—NQO1—urinary bladder cancer	9.61e-06	0.000411	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.57e-06	0.00041	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—NCOR1—urinary bladder cancer	9.47e-06	0.000405	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—EP300—urinary bladder cancer	9.44e-06	0.000404	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	9.37e-06	0.000401	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.37e-06	0.000401	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCNE1—urinary bladder cancer	9.36e-06	0.0004	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.32e-06	0.000399	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GSTZ1—urinary bladder cancer	9.26e-06	0.000397	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	9.24e-06	0.000396	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TYMS—urinary bladder cancer	9.19e-06	0.000393	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—MMP9—urinary bladder cancer	9.15e-06	0.000392	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—TYMS—urinary bladder cancer	9e-06	0.000385	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9e-06	0.000385	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EGFR—urinary bladder cancer	8.94e-06	0.000383	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—ERCC2—urinary bladder cancer	8.9e-06	0.000381	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—GSTM1—urinary bladder cancer	8.9e-06	0.000381	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—NCOR1—urinary bladder cancer	8.9e-06	0.000381	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GSTO2—urinary bladder cancer	8.78e-06	0.000376	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—NAT1—urinary bladder cancer	8.78e-06	0.000376	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EP300—urinary bladder cancer	8.68e-06	0.000371	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.57e-06	0.000367	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—GPX1—urinary bladder cancer	8.52e-06	0.000365	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TNF—urinary bladder cancer	8.52e-06	0.000365	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KRAS—urinary bladder cancer	8.45e-06	0.000362	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—SRC—urinary bladder cancer	8.44e-06	0.000361	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.39e-06	0.000359	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	8.38e-06	0.000359	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ERCC2—urinary bladder cancer	8.37e-06	0.000358	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.26e-06	0.000354	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.2e-06	0.000351	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.13e-06	0.000348	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MYC—urinary bladder cancer	8.03e-06	0.000344	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—UGT2B7—urinary bladder cancer	8.03e-06	0.000344	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	8.01e-06	0.000343	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—GSTP1—urinary bladder cancer	8.01e-06	0.000343	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TERT—urinary bladder cancer	8e-06	0.000343	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	7.99e-06	0.000342	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	7.92e-06	0.000339	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—MTHFR—urinary bladder cancer	7.87e-06	0.000337	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.75e-06	0.000332	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	7.7e-06	0.00033	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	7.64e-06	0.000327	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.59e-06	0.000325	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.53e-06	0.000322	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	7.49e-06	0.000321	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.46e-06	0.00032	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—TYMS—urinary bladder cancer	7.45e-06	0.000319	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—ESR1—urinary bladder cancer	7.44e-06	0.000318	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EGFR—urinary bladder cancer	7.4e-06	0.000317	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—GSTM1—urinary bladder cancer	7.36e-06	0.000315	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—NCOR1—urinary bladder cancer	7.36e-06	0.000315	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.27e-06	0.000311	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYP4B1—urinary bladder cancer	7.23e-06	0.00031	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—ATM—urinary bladder cancer	7.19e-06	0.000308	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—urinary bladder cancer	7.18e-06	0.000307	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDK4—urinary bladder cancer	7.16e-06	0.000307	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—GPX1—urinary bladder cancer	7.05e-06	0.000302	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TNF—urinary bladder cancer	7.04e-06	0.000302	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.04e-06	0.000301	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	7.02e-06	0.0003	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—KRAS—urinary bladder cancer	6.99e-06	0.000299	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—RB1—urinary bladder cancer	6.97e-06	0.000298	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.92e-06	0.000296	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ERCC2—urinary bladder cancer	6.92e-06	0.000296	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SLC19A1—urinary bladder cancer	6.83e-06	0.000292	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—PPARG—urinary bladder cancer	6.78e-06	0.00029	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—urinary bladder cancer	6.76e-06	0.000289	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PRSS3—urinary bladder cancer	6.66e-06	0.000285	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	6.64e-06	0.000284	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—CREBBP—urinary bladder cancer	6.52e-06	0.000279	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—MTHFR—urinary bladder cancer	6.51e-06	0.000279	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PPARG—urinary bladder cancer	6.38e-06	0.000273	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	6.29e-06	0.000269	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NAT1—urinary bladder cancer	6.29e-06	0.000269	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—RB1—urinary bladder cancer	6.23e-06	0.000267	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CREBBP—urinary bladder cancer	6.13e-06	0.000262	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	6.12e-06	0.000262	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—urinary bladder cancer	5.94e-06	0.000254	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	5.75e-06	0.000246	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN2A—urinary bladder cancer	5.48e-06	0.000234	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—TYMP—urinary bladder cancer	5.32e-06	0.000228	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PPARG—urinary bladder cancer	5.28e-06	0.000226	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	5.18e-06	0.000222	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	5.17e-06	0.000221	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	5.13e-06	0.00022	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CREBBP—urinary bladder cancer	5.07e-06	0.000217	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.04e-06	0.000216	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTGS2—urinary bladder cancer	5.02e-06	0.000215	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	5.01e-06	0.000214	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.97e-06	0.000213	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	4.89e-06	0.000209	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	4.86e-06	0.000208	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NAT1—urinary bladder cancer	4.86e-06	0.000208	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—NAT2—urinary bladder cancer	4.81e-06	0.000206	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.78e-06	0.000205	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	4.77e-06	0.000204	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	4.76e-06	0.000204	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	4.68e-06	0.0002	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.63e-06	0.000198	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND1—urinary bladder cancer	4.63e-06	0.000198	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.57e-06	0.000195	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN1A—urinary bladder cancer	4.48e-06	0.000192	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.45e-06	0.00019	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.44e-06	0.00019	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.44e-06	0.00019	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTEN—urinary bladder cancer	4.38e-06	0.000187	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.36e-06	0.000187	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—EP300—urinary bladder cancer	4.26e-06	0.000182	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—EP300—urinary bladder cancer	4.17e-06	0.000179	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—RRM2—urinary bladder cancer	4.15e-06	0.000178	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTGS2—urinary bladder cancer	4.15e-06	0.000178	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	4.15e-06	0.000178	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.06e-06	0.000174	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.01e-06	0.000171	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MYC—urinary bladder cancer	3.87e-06	0.000166	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ENO2—urinary bladder cancer	3.85e-06	0.000165	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—HPGDS—urinary bladder cancer	3.85e-06	0.000165	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—TYMP—urinary bladder cancer	3.81e-06	0.000163	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.78e-06	0.000162	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GSTT1—urinary bladder cancer	3.73e-06	0.00016	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYC—urinary bladder cancer	3.71e-06	0.000159	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.69e-06	0.000158	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.65e-06	0.000156	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTEN—urinary bladder cancer	3.62e-06	0.000155	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.49e-06	0.00015	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—EP300—urinary bladder cancer	3.45e-06	0.000148	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.45e-06	0.000148	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.45e-06	0.000148	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.36e-06	0.000144	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—NQO1—urinary bladder cancer	3.1e-06	0.000133	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.09e-06	0.000132	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—urinary bladder cancer	3.05e-06	0.00013	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.98e-06	0.000127	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.96e-06	0.000127	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.95e-06	0.000126	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.93e-06	0.000125	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.93e-06	0.000125	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.83e-06	0.000121	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.76e-06	0.000118	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.76e-06	0.000118	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.7e-06	0.000115	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.69e-06	0.000115	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.68e-06	0.000115	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.67e-06	0.000114	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.67e-06	0.000114	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GSTP1—urinary bladder cancer	2.59e-06	0.000111	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.58e-06	0.00011	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.43e-06	0.000104	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.41e-06	0.000103	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—TYMS—urinary bladder cancer	2.4e-06	0.000103	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—NCOR1—urinary bladder cancer	2.38e-06	0.000102	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GSTM1—urinary bladder cancer	2.38e-06	0.000102	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.3e-06	9.85e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GPX1—urinary bladder cancer	2.28e-06	9.74e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.27e-06	9.74e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ERCC2—urinary bladder cancer	2.23e-06	9.56e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.22e-06	9.51e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.22e-06	9.49e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.13e-06	9.12e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.13e-06	9.12e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.12e-06	9.07e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—MTHFR—urinary bladder cancer	2.1e-06	8.99e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.1e-06	8.98e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.07e-06	8.85e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.04e-06	8.71e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.94e-06	8.32e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.94e-06	8.32e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.93e-06	8.27e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.88e-06	8.07e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.86e-06	7.94e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.85e-06	7.93e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.77e-06	7.59e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.72e-06	7.37e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.72e-06	7.35e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.7e-06	7.29e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.7e-06	7.29e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.7e-06	7.29e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.67e-06	7.13e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.64e-06	7e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.63e-06	6.98e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.6e-06	6.86e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.6e-06	6.85e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.57e-06	6.7e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.52e-06	6.5e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.5e-06	6.44e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.45e-06	6.22e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.43e-06	6.13e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.39e-06	5.93e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.38e-06	5.92e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.34e-06	5.74e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.33e-06	5.7e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.33e-06	5.67e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.32e-06	5.64e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.32e-06	5.64e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.31e-06	5.59e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.28e-06	5.48e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.28e-06	5.48e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.26e-06	5.41e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.26e-06	5.4e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.24e-06	5.32e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.24e-06	5.3e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.22e-06	5.22e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.21e-06	5.2e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.2e-06	5.14e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.2e-06	5.14e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.17e-06	5.02e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTEN—urinary bladder cancer	1.17e-06	5e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.16e-06	4.98e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.15e-06	4.92e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.13e-06	4.83e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—EP300—urinary bladder cancer	1.11e-06	4.77e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.06e-06	4.54e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.03e-06	4.42e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	9.6e-07	4.11e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PPARG—urinary bladder cancer	9.43e-07	4.04e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	9.06e-07	3.88e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.61e-07	3.69e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PPARG—urinary bladder cancer	8.6e-07	3.68e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTEN—urinary bladder cancer	8.37e-07	3.58e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	8.26e-07	3.54e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.01e-07	3.43e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—EP300—urinary bladder cancer	7.98e-07	3.42e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.92e-07	3.39e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.92e-07	3.39e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.58e-07	3.25e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.44e-07	3.19e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	7.42e-07	3.18e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7e-07	2.99e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6.77e-07	2.9e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTEN—urinary bladder cancer	6.47e-07	2.77e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—EP300—urinary bladder cancer	6.17e-07	2.64e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.9e-07	2.53e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.67e-07	2.43e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.63e-07	2.41e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.45e-07	2.33e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.46e-07	1.91e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.89e-07	1.67e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.71e-07	1.59e-05	CbGpPWpGaD
